Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)

Yael Pri-Paz Basson; Oshrat E. Tayer-Shifman; Rawand Naser; Shelly Tartakover Matalon; Oded Kimhi; Raz Gepstein; Tamar Halperin; Tomer Ziv-Baran; Amit Ziv; Roma Parikh; Shaye Kivity; Yair Levy

doi:10.1007/s10067-022-06412-8

Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)

Yael Pri-Paz Basson, Oshrat E. Tayer-Shifman, Rawand Naser, Shelly Tartakover Matalon, Oded Kimhi, Raz Gepstein, Tamar Halperin, Tomer Ziv-Baran, Amit Ziv, Roma Parikh, Shaye Kivity^*, Yair Levy

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

In the original published version of the above article, the co-author‘s name was incorrectly presented as "Oshrat E. Tayar‑Shifman". This is now corrected as "Oshrat E. Tayer- Shifman" and cited correctly as, "Tayer-Shifman, O.E.". The original article has been corrected.

Original language	English
Pages (from-to)	3925
Number of pages	1
Journal	Clinical Rheumatology
Volume	41
Issue number	12
DOIs	https://doi.org/10.1007/s10067-022-06412-8
State	Published - Dec 2022

Access to Document

10.1007/s10067-022-06412-8

Fingerprint

Dive into the research topics of 'Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)'. Together they form a unique fingerprint.

Cite this

Pri-Paz Basson, Y., Tayer-Shifman, O. E., Naser, R., Tartakover Matalon, S., Kimhi, O., Gepstein, R., Halperin, T., Ziv-Baran, T., Ziv, A., Parikh, R., Kivity, S., & Levy, Y. (2022). Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z). Clinical Rheumatology, 41(12), 3925. https://doi.org/10.1007/s10067-022-06412-8

@article{70a8812a07f54be28ee743552e7d3df5,

title = "Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)",

abstract = "In the original published version of the above article, the co-author{\textquoteleft}s name was incorrectly presented as {"}Oshrat E. Tayar‑Shifman{"}. This is now corrected as {"}Oshrat E. Tayer- Shifman{"} and cited correctly as, {"}Tayer-Shifman, O.E.{"}. The original article has been corrected.",

author = "{Pri-Paz Basson}, Yael and Tayer-Shifman, {Oshrat E.} and Rawand Naser and {Tartakover Matalon}, Shelly and Oded Kimhi and Raz Gepstein and Tamar Halperin and Tomer Ziv-Baran and Amit Ziv and Roma Parikh and Shaye Kivity and Yair Levy",

note = "Publisher Copyright: {\textcopyright} The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2022.",

year = "2022",

month = dec,

doi = "10.1007/s10067-022-06412-8",

language = "אנגלית",

volume = "41",

pages = "3925",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "12",

}

Pri-Paz Basson, Y, Tayer-Shifman, OE, Naser, R, Tartakover Matalon, S, Kimhi, O, Gepstein, R, Halperin, T, Ziv-Baran, T, Ziv, A, Parikh, R, Kivity, S & Levy, Y 2022, 'Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)', Clinical Rheumatology, vol. 41, no. 12, pp. 3925. https://doi.org/10.1007/s10067-022-06412-8

Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z). / Pri-Paz Basson, Yael; Tayer-Shifman, Oshrat E.; Naser, Rawand et al.
In: Clinical Rheumatology, Vol. 41, No. 12, 12.2022, p. 3925.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)

AU - Pri-Paz Basson, Yael

AU - Tayer-Shifman, Oshrat E.

AU - Naser, Rawand

AU - Tartakover Matalon, Shelly

AU - Kimhi, Oded

AU - Gepstein, Raz

AU - Halperin, Tamar

AU - Ziv-Baran, Tomer

AU - Ziv, Amit

AU - Parikh, Roma

AU - Kivity, Shaye

AU - Levy, Yair

N1 - Publisher Copyright: © The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR) 2022.

PY - 2022/12

Y1 - 2022/12

N2 - In the original published version of the above article, the co-author‘s name was incorrectly presented as "Oshrat E. Tayar‑Shifman". This is now corrected as "Oshrat E. Tayer- Shifman" and cited correctly as, "Tayer-Shifman, O.E.". The original article has been corrected.

AB - In the original published version of the above article, the co-author‘s name was incorrectly presented as "Oshrat E. Tayar‑Shifman". This is now corrected as "Oshrat E. Tayer- Shifman" and cited correctly as, "Tayer-Shifman, O.E.". The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85140040941&partnerID=8YFLogxK

U2 - 10.1007/s10067-022-06412-8

DO - 10.1007/s10067-022-06412-8

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 36251175

AN - SCOPUS:85140040941

SN - 0770-3198

VL - 41

SP - 3925

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 12

ER -

Pri-Paz Basson Y, Tayer-Shifman OE, Naser R, Tartakover Matalon S, Kimhi O, Gepstein R et al. Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z). Clinical Rheumatology. 2022 Dec;41(12):3925. doi: 10.1007/s10067-022-06412-8

Correction to: Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients (Clinical Rheumatology, (2022), 41, 12, (3879-3885), 10.1007/s10067-022-06348-z)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this